Anhui Huaheng Biotechnology Co. Ltd. A (688639) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.015x

Based on the latest financial reports, Anhui Huaheng Biotechnology Co. Ltd. A (688639) has a cash flow conversion efficiency ratio of 0.015x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥40.01 Million ≈ $5.85 Million USD) by net assets (CN¥2.67 Billion ≈ $390.37 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Anhui Huaheng Biotechnology Co. Ltd. A - Cash Flow Conversion Efficiency Trend (2012–2024)

This chart illustrates how Anhui Huaheng Biotechnology Co. Ltd. A's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read total liabilities of Anhui Huaheng Biotechnology Co. Ltd. A for a breakdown of total debt and financial obligations.

Anhui Huaheng Biotechnology Co. Ltd. A Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Anhui Huaheng Biotechnology Co. Ltd. A ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Formosa Advanced Technologies Co Ltd TW:8131	0.027x
Manchester United Ltd F:MUF	-0.007x
Aktis Oncology, Inc. Common stock NASDAQ:AKTS	0.097x
Huangshan Novel Co Ltd SHE:002014	0.124x
Huachangda Intelligent Equipment Group Co Ltd SHE:300278	0.033x
Wuhan Zhongyuan Huadian Sci Tech SHE:300018	0.071x
BALTIC CLASSIF.GR LS 001 F:983	N/A
Yuanta Futures Co Ltd TWO:6023	0.030x

Annual Cash Flow Conversion Efficiency for Anhui Huaheng Biotechnology Co. Ltd. A (2012–2024)

The table below shows the annual cash flow conversion efficiency of Anhui Huaheng Biotechnology Co. Ltd. A from 2012 to 2024. For the full company profile with market capitalisation and key ratios, see Anhui Huaheng Biotechnology Co. Ltd. A (688639) total market value.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	CN¥2.56 Billion ≈ $374.37 Million	CN¥199.79 Million ≈ $29.24 Million	0.078x	-53.14%
2023-12-31	CN¥1.83 Billion ≈ $267.15 Million	CN¥304.28 Million ≈ $44.53 Million	0.167x	-30.91%
2022-12-31	CN¥1.48 Billion ≈ $216.81 Million	CN¥357.43 Million ≈ $52.30 Million	0.241x	+198.23%
2021-12-31	CN¥1.18 Billion ≈ $173.13 Million	CN¥95.70 Million ≈ $14.00 Million	0.081x	-63.84%
2020-12-31	CN¥489.78 Million ≈ $71.67 Million	CN¥109.57 Million ≈ $16.03 Million	0.224x	-54.55%
2019-12-31	CN¥368.68 Million ≈ $53.95 Million	CN¥181.48 Million ≈ $26.56 Million	0.492x	+71.02%
2018-12-31	CN¥310.29 Million ≈ $45.41 Million	CN¥89.31 Million ≈ $13.07 Million	0.288x	-42.61%
2017-12-31	CN¥210.73 Million ≈ $30.84 Million	CN¥105.69 Million ≈ $15.47 Million	0.502x	+60.67%
2016-12-31	CN¥176.26 Million ≈ $25.79 Million	CN¥55.02 Million ≈ $8.05 Million	0.312x	+1.31%
2015-12-31	CN¥114.46 Million ≈ $16.75 Million	CN¥35.27 Million ≈ $5.16 Million	0.308x	-45.45%
2014-12-31	CN¥54.10 Million ≈ $7.92 Million	CN¥30.56 Million ≈ $4.47 Million	0.565x	-71.96%
2013-12-31	CN¥20.46 Million ≈ $2.99 Million	CN¥41.21 Million ≈ $6.03 Million	2.014x	+332.61%
2012-12-31	CN¥7.80 Million ≈ $1.14 Million	CN¥-6.76 Million ≈ $-988.72K	-0.866x	--

About Anhui Huaheng Biotechnology Co. Ltd. A

SHG:688639 China Biotechnology

Market Cap

$1.01 Billion

CN¥6.93 Billion CNY

Market Cap Rank

#9090 Global

#2449 in China

Share Price

CN¥27.70

Change (1 day)

-1.07%

52-Week Range

CN¥27.52 - CN¥41.34

All Time High

CN¥85.44